Biologics

Bio2 Technologies received FDA approval to begin enrolling patients in an investigational device exemption clinical study to evaluate Vitrium as a cervical interbody fusion device.

Joost de Bruijn, PhD, is the CEO of Kuros Biosciences.

Histogenics develops restorative cell therapies for orthopedic pain relief.

Imagion Biosystems is commercializing a form of medical imaging that uses biosafe nanoparticles to detect cancer, according to Proactive Investors Australia.

Regenerative medicine company SpinalCyte was issued new patents in Hong Kong and Europe.

Guy Cook is the CEO of Lattice Biologics.

Cellect Biotechnology received several patent grants for its Apograft technology.

OsteoRemedies launched the first FDA-cleared dual-antibiotic spacer system and bone cement offering with gentamicin and vancomycin.  

MTF Biologics and Academy Medical partnered to bring human allograft tissues to Veteran Affairs medical centers across the U.S.

ORTHOReBIRTH USA signed a letter of intent to develop new biologic products with Loubert Suddaby, MD.